Charles Schwab Investment Management Inc. Increases Stock Position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Charles Schwab Investment Management Inc. lifted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 578,409 shares of the company’s stock after buying an additional 12,906 shares during the period. Charles Schwab Investment Management […]
Charles Schwab Investment Management Inc. lifted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 2.3% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 578,409 shares of the company’s stock after buying an additional 12,906 shares during the period. Charles Schwab Investment Management […]
